Australia Clinical Trial Equipments & Ancillary Solutions Market Market Report 2023 to 2030

Australia Clinical Trial Equipments & Ancillary Solutions Market Analysis

$ 3999

Australia Clinical Trial Equipment & Ancillary Solutions Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Clinical Trial Equipment & Ancillary Solutions is expanding as a result of rising R&D expenditure in this sector. Increasing clinical trials, development in technology and increasing demand for personalized medicine are fueling the development of accurate clinical trial equipment and ancillary solutions market. Some of the key players in the global Clinical Trial Equipment & Ancillary Solutions Market include Thermo Fisher Scientific Inc., Covance Inc., LabCorp, Parexel International Corporation, PRA Health Sciences, Inc., ICON plc, Medpace Holdings, Inc., Syneos Health Inc., IQVIA Holdings Inc., Charles River Laboratories International, Inc.

ID: IN10AUHS032 CATEGORY: Healthcare Services GEOGRAPHY: Australia AUTHOR: Aneri Parekh

Buy Now

Australia Clinical Trial Equipments & Ancillary Solutions Market Executive Summary

Australia Clinical Trial Equipments & Ancillary Solutions Market is valued at around $32.4 Bn in 2022 and is projected to reach $67.5 Bn by 2030, exhibiting a CAGR of 9.6% during the forecast period 2023-2030.

Clinical Trial Equipment & Ancillary Solutions Market refers to the market for equipment, services and technologies used for the planning, execution, logistics and supply chain management of clinical trials. It also includes data management solutions, imaging systems, laboratory equipment and patient recruitment and retention.

Covid-19 pandemic had temporarily slowed down the progress of clinical trials in 2020-2021 owing to lockdowns and social distancing which had affected market negatively. Regardless of this requirement for effective treatment of Covid-19 and other diseases has increased a demand for clinical trial equipment and ancillary services post Covid-19.

Increasing number of clinical trials and Covid-19 has increased demand for advanced technology and remote monitoring. Trend of personalised medicine is increasing which has led to more investment in research and development. All these factors are giving boost to clinical trial equipment and ancillary solutions.

There are many players in clinical trial equipment and ancillary solutions but Thermo Fisher Scientific Inc., Covance Inc., LabCorp, Parexel International Corporation, PRA Health Sciences, Inc., ICON plc, Medpace Holdings, Inc., Syneos Health Inc., IQVIA Holdings Inc., Charles River Laboratories International, Inc. are major global players.

Increasing communicable and non-communicable diseases has increased co-morbidities in population. Novel communicable diseases will require effective treatment plan which is giving rise to clinical trial equipment and ancillary solution market. The market still has many difficulties with regard to obtaining regulatory permission and funding for clinical trials and development of new technologies, skilled professionals and high cost of equipment and services.

Market Dynamics

Drivers of Australia Clinical Trial Equipment & Ancillary Solutions Market:

Increasing Number of Clinical Trials: Covid-19 has changed the market dynamics and after pandemic it has given boost to the market in clinical trials globally. This is raising the demand for clinical trial equipment and ancillary solutions market.

Development in Technologies: New Technology development and advancement in technologies like laboratory equipment, clinical trial equipment and other ancillaries has driven the demand in this sector.

Increasing R&D Investment: Industries like pharmaceutical and biotechnology are investing in heavily in research and development in the clinical trial equipment and ancillaries. This is fueling the demand for development of better equipment and methods for the clinical trials and effective ancillary solutions.

Increasing Outsourcing of Clinical Trials: Contract research organisations (CRO) are increasing which gave a rise to outsourcing of the clinical trials, which is boosting demand for clinical trial equipment and ancillary solutions.

Growing Interest in Personalised Medicine: Demand for personalised medicine is increasing and for fulfilling this demand advancements in clinical trial equipment and ancillary solutions will be needed.

Remote Monitoring: Due to Covid-19 pandemic remote monitoring has been increased which can reduce cost of clinical trials and requires efficient equipment for clinical trials. It will increase demand for clinical trial equipment and ancillary solutions.

Restraints of Australia Clinical Trial Equipment & Ancillary Solutions Market:

High Cost of Equipment and Services: Cost of clinical trial equipment and ancillary solutions are higher which can be a restraint for entry into the market of clinical trial equipment and ancillary solutions. It can be difficult for smaller organisations and researchers to conduct clinical trials.

Complex Regulatory Procedures: Compliance with regulatory requirements can be complex and it is time consuming which adds more cost to conduct clinical trials. It requires ongoing investment and greater collaboration with the streamline regulatory process.

Data Privacy and Security: Process of clinical trials involves huge data collection which includes confidential data and to keep these data safe and secure is bigger challenge. It requires strict regulations for meeting these requirements and adds more cost to clinical trials.

Shortage of Skilled Professionals: Clinical trials requires skilled professionals like researchers, clinicians and technical staff. There is shortage in skilled professionals in this industry. Which can hamper the clinical trials and eventually be a restraint for clinical trial equipment and ancillary solutions market.

Key players

Thermo Fisher Scientific Inc. Waters Corporation Danaher Corporation PerkinElmer Inc. Agilent Technologies, Inc. Bio-Rad Laboratories, Inc. GE Healthcare Life Sciences Bruker Corporation Eppendorf AG Olympus Corporation

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Australia Clinical Trial Equipment & Ancillary Solutions Market

By Product:

Sourcing
- Rental
- Procurement
Logistics
- Transportation
- Packaging
- Other
Services
- Calibrations
- Equipment servicing
- Other
Others

By Phase:

Phase I
Phase II
Phase III
Phase IV

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.